Praxis Precision Medicines, Inc. SEC filings PRAX
Praxis Precision Medicines, Inc. has 510 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Other events
|
Jul 7, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Auditor change
|
Jul 2, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 144 | Notice of proposed sale | Jun 24, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 22, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 14, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 14, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 30, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 14, 2026 | Apr 14, 2026 |
| 8-K |
Current report
Other events
|
Apr 6, 2026 | Apr 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 27, 2026 | — |
| S-8 | Employee stock plan registration | Feb 19, 2026 | — |
| 10-K | Annual report | Feb 19, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 19, 2026 | Feb 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 6, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Feb 10, 2026 | Feb 6, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 4 | Insider transaction | Jan 13, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 13, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 12, 2026 | Jan 8, 2026 |
| 3 | Initial insider ownership | Jan 12, 2026 | Jan 8, 2026 |
| 3 | Initial insider ownership | Jan 12, 2026 | Jan 8, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 4 | Insider transaction | Jan 9, 2026 | Jan 7, 2026 |
| 3 | Initial insider ownership | Jan 9, 2026 | Jan 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Other events
|
Jan 7, 2026 | Jan 6, 2026 |
| 424B5 | Prospectus supplement | Jan 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
Jan 6, 2026 | Jan 6, 2026 |
| 424B5 | Prospectus supplement | Jan 6, 2026 | — |
| 4 | Insider transaction | Dec 31, 2025 | Dec 30, 2025 |
| 8-K |
Current report
Other events
|
Dec 29, 2025 | Dec 29, 2025 |
| 8-K |
Current report
Other events
|
Dec 11, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 14, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 20, 2025 |
| 144 | Notice of proposed sale | Nov 20, 2025 | — |
| 144 | Notice of proposed sale | Nov 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 7, 2025 | — |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 3, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 21, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Other events
|
Oct 20, 2025 | Oct 16, 2025 |
| 424B5 | Prospectus supplement | Oct 20, 2025 | — |
| 4 | Insider transaction | Oct 17, 2025 | Oct 16, 2025 |
| 424B5 | Prospectus supplement | Oct 16, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2025 | Oct 16, 2025 |
| 4 | Insider transaction | Sep 25, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Other events
|
Sep 5, 2025 | Sep 2, 2025 |
| 424B5 | Prospectus supplement | Sep 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 2, 2025 | — |
| 3 | Initial insider ownership | Aug 19, 2025 | Aug 18, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 5, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| 10-Q | Quarterly report | Aug 4, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 17, 2025 | Jul 17, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2025 | Jun 26, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 6, 2025 | — |
| 4 | Insider transaction | May 19, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 14, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 2, 2025 | May 2, 2025 |
| 10-Q | Quarterly report | May 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 2, 2025 | May 2, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 26, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 19, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| S-8 | Employee stock plan registration | Feb 28, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2025 | Feb 28, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 12, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2025 | — |
| 8-K |
Current report
Results of operations
|
Jan 29, 2025 | Jan 12, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 14, 2025 | Jan 10, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 7, 2025 |
| S-3ASR | Automatic shelf registration | Dec 23, 2024 | — |
| 4 | Insider transaction | Nov 19, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 19, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 15, 2024 | Nov 14, 2024 |
| 4 | Insider transaction | Nov 15, 2024 | Nov 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 144 | Notice of proposed sale | Nov 14, 2024 | — |
| 144 | Notice of proposed sale | Nov 14, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 6, 2024 | Nov 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 22, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Oct 15, 2024 | Oct 11, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 23, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| 4 | Insider transaction | Jul 31, 2024 | Jul 29, 2024 |
| SC 13G | Ownership over 5% (passive) | Jul 1, 2024 | — |
| S-8 POS | Form s-8 pos | Jun 10, 2024 | — |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
May 13, 2024 | May 13, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 27, 2024 |
| 424B5 | Prospectus supplement | Mar 29, 2024 | — |
| 424B5 | Prospectus supplement | Mar 27, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 26, 2024 | Mar 26, 2024 |
| EFFECT | Filing | Mar 12, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRAX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1689548
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.